The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex.
about
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infectionNegative regulation of cytoplasmic RNA-mediated antiviral signalingHigh-risk human papillomavirus targets crossroads in immune signalingWAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motilityModulation of NF-κB signalling by microbial pathogensHuman papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus.NF-κB-induced KIAA1199 promotes survival through EGFR signalling.Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune responseThe interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1.Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalizationHuman papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activationRelationship among human papillomavirus infection, p16(INK4a), p53 and NF-κB activation in penile cancer from northern ThailandHuman papillomavirus and disease mechanisms: relevance to oral and cervical cancers.Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification.Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB.The papillomavirus E7 proteins.Oncogenic activities of human papillomaviruses.Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction.The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.The human papillomavirus E7 oncoprotein as a regulator of transcription.Manipulation of the innate immune response by human papillomaviruses.Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signalingZinc finger A20 and NF-κB correlate with high-risk human papillomavirus of squamous cell carcinoma patients.Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer.Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus.The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death.The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes.Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis.NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association.Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix.
P2860
Q27002467-FF7C8ADA-590A-44E7-8352-6B6228D0FC20Q27487296-547D6652-FD47-41B3-B477-FA87C6670E21Q28084802-8BB4EED7-E8C9-4AB4-A62B-11553F01DCD3Q28507062-E051A294-2284-4C26-9585-B8C019958353Q28709497-72290CC3-C383-4690-A765-3D3C87FB26F6Q33851664-20B83034-4DB5-4D2A-B9E2-3E1EA08BD3DDQ34309882-4583CC09-E87F-4031-ACE4-EF1BB0EAE0C3Q34563758-9C83824B-3077-4D63-AE63-0AA750737842Q34743768-BD61712F-1E21-4CCC-B04C-CDD16A67576AQ35245080-ADB1D777-4820-4BF9-97E7-CE0F66AE2EA9Q35488924-56A6D1BE-471B-4EDE-AD97-66B6B45ADDA9Q35787928-A7314EF4-F71A-466C-BA6A-714C32946B1AQ36216805-2292B540-C9BE-40C2-8B1F-4A45FC12482DQ36217010-16C59557-2521-4DD0-BFA4-EE98E6F7E752Q36305948-45BB6887-C364-4E38-A577-F96FBD30C43CQ36827288-9DFDEA61-C495-4C80-9E8B-E2E017655395Q37002546-54D0D763-404F-417A-958E-29E4007FD4F2Q37192229-08E615FF-727D-42F0-9D27-37F709E03895Q37198662-4C40143F-A099-43DE-88BB-EAEA8D5AFA74Q37316158-EB7A5864-8810-4FC2-B43F-DCE5D0C21F36Q37748135-DDA4DA97-8919-4DDE-A92B-ADCCF1F27C98Q38343954-2A63872A-7C49-42E7-ACE0-A9185A30C5DFQ38428005-A8166E5A-4174-4D0E-A525-14DEE8D0F15CQ39000409-671685D7-EAD2-4334-BD87-AD2177E5350BQ39003287-D250D5F7-D0BC-4DFF-9672-488E368A4D3EQ39083904-33569EB7-0C23-4F44-8BB0-8B38FA4E07D6Q39127526-FAFF7FF4-AD51-4205-A019-86A7AA51B5FBQ39445934-4866959C-9C20-462E-B87C-10D289BDAC8DQ40361594-B8850E2E-CDD5-46D2-8183-2863666532F8Q40430288-B6E08F88-24DF-47EC-99BD-8FEC6F95DF96Q40444191-FF770D00-2299-4809-B69F-AD2B94E50FD1Q40543156-E603349D-7A09-4431-BC73-D7456C650CFAQ40645798-09D65663-5A10-4A7A-9CD6-68F6D67DAAA3Q41055909-2998693B-4307-4048-B86A-D9B5C7EBA0E9Q41837402-9F5E76E5-E37B-42D1-BFE5-B1C3F7385C67Q42030463-9216AAA1-3A58-484B-BE6C-4464FA12DFFDQ42218400-D619179C-2081-49A5-8CE1-3D1B502B096BQ42411008-746FF2C9-70E8-4412-80F4-6B53EB107007Q44269684-991E92AE-6642-4138-A4D1-AD030C29A677Q47775964-BCF052A7-B6DD-456E-9DD6-E50AA69972EE
P2860
The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The human papillomavirus oncop ...... g the Ikappa B kinase complex.
@en
type
label
The human papillomavirus oncop ...... g the Ikappa B kinase complex.
@en
prefLabel
The human papillomavirus oncop ...... g the Ikappa B kinase complex.
@en
P2093
P2860
P356
P1476
The human papillomavirus oncop ...... g the Ikappa B kinase complex.
@en
P2093
Andreas Möller
Dimitry Spitkovsky
M Lienhard Schmitz
Steffen P Hehner
Thomas G Hofmann
P2860
P304
25576-25582
P356
10.1074/JBC.M201884200
P407
P577
2002-05-01T00:00:00Z